For the first time, a team of experts from the Technical University of Munich (TUM), RWTH Aachen University, and the German ...

IDH-mutant glioma, caused by abnormalities in a specific gene (IDH), is the most common malignant brain tumor among young ...

A new clinical study published in the International Journal of Gynecological Cancer reports encouraging results for women ...

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, ...

The FDA-approved drug combination specifically targets low-grade serous ovarian cancer, which primarily affects younger women ...

GSK licenses Noetik’s AI foundation models in anchor partnership to transform cancer therapeutic research and development ...

Aston Sci. Inc., a clinical-stage biopharmaceutical company pioneering next-generation therapeutic cancer vaccines, announced ...

Gilead is making a move in the hunt for antibody-drug conjugates (ADCs) that target solid tumors by tapping Tubulis, a German biotech that specializes in the molecules, to collaboratively discover and ...

A recent study published in the medical journal Gut has revealed a novel cancer-promoting mechanism of Streptococcus ...

The U.S. Food and Drug Administration (FDA) has granted fast track designation to Alessa Therapeutics for its lead product ...